Description
Overview
The Scripps 7th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2024 delivers a comprehensive curriculum focused on the cardiovascular health of cancer patients and survivors. This on-demand symposium covers state-of-the-art clinical topics in cardiomyopathy and cardio-oncology, emphasizing the diagnosis, treatment, and management of cardiovascular toxicities associated with cancer therapies.
On-demand cardiology education — accessible anytime, anywhere.
Format: 29 videos, 1 PDF
Total size: 3.47 GB
Agenda
This symposium presents expert discussions and updates on cardiomyopathy and cardio-oncology with a focus on practical application and clinical relevance.
- Cancer-Associated Thrombosis
- Cardiotoxicity Anthracyclines
- Cardiotoxicity Immunotherapy
- Comprehensive Management of Pulmonary Embolism
- Diagnosis of Sarcoid
- Hypertrophic Cardiomyopathy Diagnosis and Treatment
- Imaging of Sarcoid
- MRI Imaging in Cardiotoxicity
- Panel Discussion Q&A (Session I)
- Treatment of Sarcoid
- Cardiac Amyloidosis Mimickers
- MRI Imaging in Amyloid
- Nuclear Imaging in Amyloid
- Panel Discussion Q&A (Session II)
- What and When to Biopsy
- When is MGUS Clinically Significant
- When to Suspect Amyloidosis
- AL Amyloidosis Current Treatments
- Current Treatment of ATTR Silencers
- Current Treatment of ATTR Stabilizers
- Emerging ATTR Treatments
- Panel Discussion Q&A (Session III)
- Racial and Geographic Disparities in Amyloid
- Staging in Amyloid
- Carpal Tunnel in Amyloid
- Managing Gastrointestinal Issues in Amyloidosis
- Neuropathy and Dysautonomia in Amyloid
- Panel Discussion Q&A (Session IV)
- Transplant in Amyloidosis
Educational Objectives
- Evaluate current and emerging treatment options for cardiac amyloidosis.
- Discuss diagnosis and treatment considerations for patients with cardiac sarcoidosis.
- Assess the importance of genetic testing and treatment for genetic cardiomyopathies including hypertrophic cardiomyopathy.
- Analyze best practices in the multidisciplinary monitoring and management of cardiac toxicity in patients undergoing cancer therapy.
- Employ management strategies for venous thromboembolism and other cardiovascular complications in cancer patients.
- Demonstrate the importance of ongoing cardiac disease monitoring in cancer survivors.
Speakers
This symposium features nationally recognized experts in cardiology and oncology who present current best practices and clinical updates relevant to cardiomyopathy and cardio-oncology.
Target Audience
This symposium is intended for a broad range of healthcare professionals involved in cardiology and oncology, including:
- Physicians
- Cardiologists
- Oncologists
- Nurses
- Nurse practitioners
- Physician assistants
- Pharmacists
- Allied health professionals
Why This Topic Matters
The Scripps 7th Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium 2024 addresses critical issues in cardio-oncology, an evolving specialty focused on managing cardiovascular complications in cancer patients. The content supports healthcare professionals in strengthening their expertise in diagnosing and treating cardiomyopathies and cardiovascular toxicities related to cancer therapy.
This educational offering from MedHub Central reinforces essential clinical knowledge and practical skills needed to enhance patient care in cardiology and oncology settings, aligning with current advances and multidisciplinary approaches.
